Sandbox Reserved 1107: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
== Asymmetric and biological unit == | == Asymmetric and biological unit == | ||
The basal 3D scene shown on this page corresponds to the asymmetric unit, which contains 4 <scene name='82/829360/4_biological_units/2'>biological units</scene> of MraYAA | The basal 3D scene shown on this page corresponds to the asymmetric unit, which contains 4 <scene name='82/829360/4_biological_units/2'>biological units</scene> of MraYAA , each of which is bound with a <scene name='82/829360/Nb7_nanobodies/2'>NB7 nanobody</scene> . Mashalidis EH, Kaeser B ''et al''. , who solved this 3D structure, were screening antibodies. They determine that the presence of NB7 does not affect MraYAA enzymatic activity or inhibition by carbacaprazamycin <ref name="seven"/>. | ||
== MraY-Carbacaprazamycin structure == | == MraY-Carbacaprazamycin structure == | ||
